Inhibikase Therapeutics IKT Q1 2026 Earnings Narrowing Losses as Pipeline Progress Takes Center Stage RSG Q1 2026 Earnings EPS Beat Driven by Operational Efficiency IN8bio Q1 2026 Earnings EPS Beat Drives Modest Stock Gain as Development Costs Remain under Control Soleno Therapeutics Inc SLNO Q1 2026 Earnings Profitability Misses Estimates Amid Zero Revenue Beazer Homes BZH Q1 2026 Earnings Surprise EPS Beat Defies Expectations PRTS Q1 2026 Earnings EPS Surprises with 4885 Beat Stock Falls 392